ARF Bio Yenilenebilir Enerji Uretim AS

ARF Bio Yenilenebilir Enerji Uretim AS

BBIST:ARFYE
10.04
TRY
-1.11
(-9.96%)
-0.66EPS
5.69BMarket Cap
2022 Y
2023 Y
2024 Y
TTM
Revenue per Share
0.5
1.49
0.79
2.42
Basic EPS, GAAP
0.03
0.55
0.04
-0.66
Free Cash Flow per Basic Share
- -
0.21
-0.12
-3.11
Dividend per Share
- -
- -
- -
- -
Book Value per Share
2.43
5.4
6.6
11.59
Tangible Book Value per Share
2.43
5.4
6.6
11.58
Basic Weighted Avg Shares
183
183
183
183
Sales/Revenue/Turnover
91
273
144
442
Operating Margin (%)
15.42
30.97
1.07
-12.46
Depreciation Expense
- -
- -
11
- -
Net Income, GAAP
5
101
8
-121
Effective Tax Rate (%)
54.57
9.89
- -
- -
Profit Margin (%)
5.47
37.09
5.55
-27.3
Working Capital
178
454
495
1,013
LT Debt
94
114
100
104
Total Equity
445
988
1,208
2,119
Return on Invested Capital (%)
- -
8.52
- -
- -
Return on Capital (%)
- -
14.04
- -
- -
Return on Common Equity (%)
- -
14.13
0.73
- -

Capital Structure

TRY

•

in mil. unless spec.
Sep'25
Mar'25
Jun'25
ST Debt
207
209
199
LT Borrowings
141
114
100
LT Finance Leases
- -
4
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
183
183
183
Market Capitalization
- -
4,885
5,686

Working Capital

TRY

•

in mil. unless spec.
Sep'25
Mar'25
Jun'25
Total Current Assets
623
1,312
1,273
Cash, Cash Equivalents & STI
6
791
716
Accounts Receivable, Net
577
342
311
Inventories
30
49
83
Total Current Liabilities
274
290
260
Payables & Accruals
- -
- -
- -
ST Debt
207
209
199
Deferred Revenue
- -
- -
- -

Growth Rates

TRY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
22.21%
Free Cash Flow
- -
- -
-154.66%
Net Income, GAAP
- -
- -
-92.13%
Sales/Revenue/Turnover
- -
- -
-47.35%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
73
144
2025
93
101
36
211
- -

Quarterly Earnings Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
0.09
0.04
2025
-0.34
-0.2
-0.16
0.05
- -

Quarterly Dividends Per Share

TRY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Company Description

Full Time Employees
41
Sector
Utilities
Industry
Alternative power generation
Address
Ankara Turkey
IPO Date
Jan 5, 2026
Website
arfbio.com
Business
ARF Bio Yenilenebilir Enerji Uretim AS is a Turkey-based renewable energy and agricultural biotechnology company specializing in circular economy solutions, biomass power generation, and sustainable fertilizer manufacturing. Founded in 2016 and headquartered in Ankara, Turkey, the company operates an integrated waste-to-energy complex in Odemis, Izmir, which converts livestock manure and agricultural organic waste into electricity, thermal energy, and organic soil amendment products. The company operates primarily through two interconnected business segments: Renewable Energy Generation and Sustainable Fertilizer Production. Its core product and service offerings comprise: renewable electricity generated via anaerobic digestion at its 4.8 MW Odemis Biogas Power Plant under a 49-year operating license valid through 2067; auxiliary electricity derived from integrated hybrid solar photovoltaic (PV) installations; certified voluntary carbon emission reduction credits and green energy attributes; solid organic fertilizers commercialized under the ARF Bio Plus brand; liquid organomineral fertilizers formulated under the ARF FERBIOS brand; multi-nutrient solid organomineral fertilizers, including ARF BIO 8-21-0 and ARF BIO 11-11-11 formulations; classical mineral fertilizers, including ARF Urea 46% N and Diammonium Phosphate (DAP 18-46-0); and organic agricultural waste treatment, digestate recycling, and soil conditioning services supplied to agricultural enterprises, farming cooperatives, and commercial distributors throughout Turkey. In recent strategic developments, ARF Bio Yenilenebilir Enerji Uretim AS completed its initial public offering on Borsa Istanbul under the ticker symbol ARFYE, issuing 47 million shares to fund facility expansions and working capital requirements. Supported by institutional shareholder Re-Pie Portfolio Management through the Re-Pie ARF Venture Capital Investment Fund, the company expanded operational capacity at its Odemis industrial complex by fully commissioning dedicated solid and liquid organomineral fertilizer processing lines. Furthermore, ARF Bio Yenilenebilir Enerji Uretim AS has advanced its hybrid renewable energy model by installing solar PV capacity alongside its baseload biogas operations and scaling commercial distribution channels for its specialty crop-nutrition products and voluntary carbon offsets.